摘要
背景:目前研究表明吸烟和饮酒与痴呆的发生率并不一致。目的:我们对吸烟和饮酒与患有痴呆的风险性之间关系进行了评估,其中对阿尔茨海默症(AD)和血管性痴呆症(VaD)病人进行了7年随访。实验设计:根据他们的吸烟和饮酒情况,我们对2004-2011年的2959位老年人痴呆症的发生率进行了回顾性分析。样本:来自重庆市3个区的6个社区。参与者:对3170位男性随访了7年。检测方法:为了评估吸烟和饮酒与患有痴呆风险之间的联系,我们建立了Cox比例风险模型。结果:通过7年随访,我们发现目前吸烟的和每天吸烟的AD和AaD的发生几率分别高于从不吸烟的人群(P<0.01)。在平衡了年龄和其它混杂因素后,目前吸烟的与增加患AD (HR= 2.14, 95% CI 1.20-4.46) 和VaD (HR= 3.42, 95% CI 1.18-4.51) 的风险性相联系;与此同时,每日饮酒与增加患AD (HR= 2.25, 95% CI 1.43-3.97) 和VaD (HR= 3.42, 95% CI 1.18-4.51)的风险性相关。另外,同时吸烟和饮酒的人比从不吸烟和饮酒的人有明显高的患有AD (HR= 3.03, 95% CI 1.65-4.19) 和VaD (HR= 3.96, 95% CI 1.64-4.71) 的风险性;而且,与目前吸烟和每日饮酒的相比,同时吸烟和饮酒的患AD和VaD的风险性更高。结论:发现目前吸烟和每日饮酒的老年人与痴呆有明显的关联性。
关键词: 饮酒,阿尔茨海默病,吸烟,血管性痴呆
Current Alzheimer Research
Title:Association of Smoking and Alcohol Drinking with Dementia Risk Among Elderly Men in China
Volume: 11 Issue: 9
Author(s): Shiming Zhou, Rui Zhou, Tingting Zhong, Rui Li, Jun Tan and Huadong Zhou
Affiliation:
关键词: 饮酒,阿尔茨海默病,吸烟,血管性痴呆
摘要: Background: Previous studies relating smoking and alcohol drinking with the incidence of dementia have been inconsistent. Objectives: We assessed whether smoking and alcohol drinking was associated with the risk of dementia, including Alzheimer disease (AD) and vascular dementia (VaD) after seven years of follow-up. Design: We prospectively analysed the incidence of dementia from 2004 to 2011 among 2959 elderly men, according to their smoking and alcohol drinking status. Setting: six neighbourhoods from three districts mentioned in Chongqing city. Participants: A total of 3170 men were followed up annually for 7 years. Measurements: Cox proportional hazards models were established to evaluate the association between smoking, alcohol drinking and the risk of dementia. Results: The incidences of AD and VaD were higher respectively in current smoking than never smoking, daily drinking than never drinking over 7 years of follow-up (p<0.01). After adjusting for age and other potential confounders, current smoking was associated with increased risk of AD (HR= 2.14, 95% CI 1.20-4.46) and VaD (HR= 3.28, 95% CI 1.14-4.52), meanwhile, daily drinking was related to increased risk of AD (HR= 2.25, 95% CI 1.43-3.97) and VaD (HR= 3.42, 95% CI 1.18-4.51). In addition, co-smoking and drinking were related to with a significantly higher risk of AD and VaD than non-smoking and drinking (HR= 3.03, 95% CI 1.65-4.19) and VaD (HR= 3.96, 95% CI 1.64-4.71). Moreover, co-smoking and drinking had higher risk of AD and VaD compared with current smoking and daily drinking. Conclusions: Current smoking and daily drinking were found to be significantly associated with dementia in elderly men.
Export Options
About this article
Cite this article as:
Zhou Shiming, Zhou Rui, Zhong Tingting, Li Rui, Tan Jun and Zhou Huadong, Association of Smoking and Alcohol Drinking with Dementia Risk Among Elderly Men in China, Current Alzheimer Research 2014; 11 (9) . https://dx.doi.org/10.2174/1567205011666141001123356
DOI https://dx.doi.org/10.2174/1567205011666141001123356 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Polyphenols and Depression: from Chemistry to Medicine
Current Pharmaceutical Biotechnology The Role of LRRK2 in Neurodegeneration of Parkinson Disease
Current Neuropharmacology Towards Newer Molecular Targets for Chronic Diabetic Complications
Current Vascular Pharmacology The Economic Costs for the Control of Cardiovascular Risk: An Overview
Current Pharmaceutical Design Pharmacological Inhibition of Protein Tyrosine Phosphatase 1B: A Promising Strategy for the Treatment of Obesity and Type 2 Diabetes Mellitus
Current Medicinal Chemistry Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer’s Disease and Involvement of Neuroinflammation
Current Alzheimer Research Development of Novel Amyloid Imaging Agents Based Upon Thioflavin S
Current Alzheimer Research Appraisal of AβPP Transgenic Mice as Models for Alzheimers Disease Amyloid Cascade
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Treatment of Large Vessel Vasculitis
Current Immunology Reviews (Discontinued) Mild Systemic Inflammation has a Neuroprotective Effect After Stroke in Rats
Current Neurovascular Research Treating Asthma as a Neuroelectrical Disorder
Inflammation & Allergy - Drug Targets (Discontinued) Interference of Glycine Transporter 1: Modulation of Cognitive Functions Via Activation of Glycine-B Site of the NMDA Receptor
Central Nervous System Agents in Medicinal Chemistry Recent updates on the dynamic association between oxidative stress and neurodegenerative disorders
CNS & Neurological Disorders - Drug Targets Genetic Risk Factors for Depression in Alzheimer´s Disease Patients
Current Alzheimer Research Brain Network Connectivity Mediates Education-related Cognitive Performance in Healthy Elderly Adults
Current Alzheimer Research New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design Dehydroepiandrosterone (DHEA): A Steroid with Multiple Effects. Is there Any Possible Option in the Treatment of Critical illness?
Current Medicinal Chemistry Phytochemicals: Potential in Management of Climacteric Neurobiology
Current Pharmaceutical Design Amyloid Beta 1-42 Inhibits Entorhinal Cortex Activity in the Beta-Gamma Range: Role of GSK-3
Current Alzheimer Research The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders
Current Topics in Medicinal Chemistry